IL135083A0 - Application of tnf antagonists as medicaments for treating septic diseases - Google Patents

Application of tnf antagonists as medicaments for treating septic diseases

Info

Publication number
IL135083A0
IL135083A0 IL13508398A IL13508398A IL135083A0 IL 135083 A0 IL135083 A0 IL 135083A0 IL 13508398 A IL13508398 A IL 13508398A IL 13508398 A IL13508398 A IL 13508398A IL 135083 A0 IL135083 A0 IL 135083A0
Authority
IL
Israel
Prior art keywords
medicaments
application
tnf antagonists
treating septic
septic diseases
Prior art date
Application number
IL13508398A
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of IL135083A0 publication Critical patent/IL135083A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13508398A 1997-10-23 1998-10-15 Application of tnf antagonists as medicaments for treating septic diseases IL135083A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19746868A DE19746868A1 (en) 1997-10-23 1997-10-23 Use of tumour necrosis factor antagonists
PCT/EP1998/006545 WO1999021582A2 (en) 1997-10-23 1998-10-15 Application of tnf antagonists as medicaments for treating septic diseases

Publications (1)

Publication Number Publication Date
IL135083A0 true IL135083A0 (en) 2001-05-20

Family

ID=7846420

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13508398A IL135083A0 (en) 1997-10-23 1998-10-15 Application of tnf antagonists as medicaments for treating septic diseases

Country Status (13)

Country Link
EP (1) EP1024831A2 (en)
JP (1) JP2001521009A (en)
KR (1) KR20010024549A (en)
CN (1) CN1163272C (en)
AU (1) AU756167B2 (en)
BR (1) BR9813114A (en)
CA (1) CA2306790A1 (en)
DE (1) DE19746868A1 (en)
HU (1) HUP0100105A3 (en)
IL (1) IL135083A0 (en)
NO (1) NO20001894D0 (en)
WO (1) WO1999021582A2 (en)
ZA (1) ZA989615B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (en) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Method of treatment of pathological syndrome and medicinal agent
UA76640C2 (en) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Method for correcting pathological immune responses and homeopathic medicinal agent
UA76639C2 (en) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Homeopathic medication and method for treating erectile dysfunctions
RU2309732C1 (en) 2006-03-13 2007-11-10 Олег Ильич Эпштейн Pressed solid oral formulation of medicinal preparation and method for preparing solid oral formulation of medicinal preparation
KR101901465B1 (en) 2010-07-15 2018-09-21 올레그 일리치 엡쉬테인 Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
SG187038A1 (en) 2010-07-15 2013-02-28 Oleg Iliich Epshtein A method of increasing the effect of an activated-potentiated form of an antibody
EP2415461B1 (en) * 2010-07-24 2012-10-31 Roche Diagnostics GmbH Stabilization of interleukin 6 in serum based solutions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626572B2 (en) * 1988-07-18 1992-08-06 Chiron Corporation Monoclonal antibodies reactive with cachectin
GB9109645D0 (en) * 1991-05-03 1991-06-26 Celltech Ltd Recombinant antibodies
NZ278607A (en) * 1994-02-07 1999-05-28 Knoll Ag Use of tnf antagonists for treating disorders involving elevated serum levels of il-6 wherein the serum levels are 500pg/ml or above

Also Published As

Publication number Publication date
BR9813114A (en) 2000-08-15
ZA989615B (en) 2000-04-20
EP1024831A2 (en) 2000-08-09
CN1163272C (en) 2004-08-25
NO20001894L (en) 2000-04-12
JP2001521009A (en) 2001-11-06
KR20010024549A (en) 2001-03-26
HUP0100105A2 (en) 2001-05-28
AU756167B2 (en) 2003-01-09
HUP0100105A3 (en) 2003-08-28
DE19746868A1 (en) 1999-04-29
CN1277556A (en) 2000-12-20
WO1999021582A2 (en) 1999-05-06
WO1999021582A3 (en) 1999-07-15
NO20001894D0 (en) 2000-04-12
CA2306790A1 (en) 1999-05-06
AU1228499A (en) 1999-05-17

Similar Documents

Publication Publication Date Title
HUP9903489A3 (en) Use of epinastine for the preparation of pharmaceutical compositions treating pain
HUP0102556A3 (en) Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds
IL132760A0 (en) Vibrator for treatment of constipation
IL117957A0 (en) Pharmaceutical compositions for the treatment of impotence
IL138129A (en) Composition for therapy of estrogen-associated disorders
HUP0003851A3 (en) Pharmaceutical composition for the treatment or prevention of glomerulopathy
HUP0003982A3 (en) The use of inhibitors of the renin-angiotensin system for producing pharmaceutical compositions using for the treatment of hypoxia or impaired metabolic function
PL315666A1 (en) Heterocyclic compounds of therapeutic properties
HUP0001263A3 (en) Methods of therapeutic administration of anti-cd4ol compounds
HUP9903684A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating depression
PL327732A1 (en) Compounds of therapeutic activity
IL135083A0 (en) Application of tnf antagonists as medicaments for treating septic diseases
HUP0000954A3 (en) Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy
HUP9801925A3 (en) Use of sodium-hydrogen-exchange-inhibitors for producing pharmaceutical compositions treating diseases caused by protozoons
GB9602162D0 (en) Treatment of waste
GB9510162D0 (en) Compositions for the treatment of skin conditions
GB9818209D0 (en) Treatment of liquid waste
HUP9903685A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating excessive aggression
HU9802142D0 (en) Use of na+/h+ -ion-exchange inhibitors for producing pharmaceutical compositions for treating and profilacting diseases of the central nerve system
EP0845990A4 (en) New use of pregnane-diones as analgesic agents
HUP9902723A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating migraine pain
ZA989940B (en) Process for the treatment of highly ammonium-loaded process waste water
GB9710054D0 (en) Treatment of diseases
HUP9902882A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating insomnia
IL121349A0 (en) Delivery of substances to injured site of the central nervous system

Legal Events

Date Code Title Description
HCA Change of name of proprietor(s) after amalgamation